Zdrowie i gospodarka · 10/03/2014
FDA Clears ZEFAZONE (Cefmetazole Sodium) for Approval via Abbreviated New Drug Applications
The FDA has determined that ZEFAZONE (cefmetazole sodium) Injection and IV Solution were not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of these products through abbreviated new drug applications.